0001209191-21-062491.txt : 20211102
0001209191-21-062491.hdr.sgml : 20211102
20211102180202
ACCESSION NUMBER: 0001209191-21-062491
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211101
FILED AS OF DATE: 20211102
DATE AS OF CHANGE: 20211102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Andersen Jill
CENTRAL INDEX KEY: 0001891047
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40703
FILM NUMBER: 211372816
MAIL ADDRESS:
STREET 1: 303 WYMAN STREET
STREET 2: SUITE 300
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adagio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001832038
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851403134
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 303 WYMAN STREET
STREET 2: SUITE 300
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 530-3600
MAIL ADDRESS:
STREET 1: 303 WYMAN STREET
STREET 2: SUITE 300
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-01
0
0001832038
Adagio Therapeutics, Inc.
ADGI
0001891047
Andersen Jill
303 WYMAN STREET
SUITE 300
WALTHAM
MA
02451
0
1
0
0
Chief Legal Officer, Secretary
Stock Option (Right to Buy)
30.65
2021-11-01
4
A
0
514863
0.00
A
2031-10-31
Common Stock
514863
514863
D
One quarter (1/4) of the option shall vest on November 1, 2022, and thereafter, the remainder of the option shall vest in 36 equal monthly installments on the 1st day of each month, subject to the Reporting Person's continuous service on each vesting date.
/s/ Dorothy Vinsky, Attorney-in-Fact
2021-11-02